fda compounding semaglutide crackdown news today proposes a new GLP-1 Maybe i’m not against compounding
Description
Ahren B, Schmitz O
Manufacturers do not require this before opening, but the community has used this practice for years
Potency loss may occur without any visible change, meaning the solution could appear intact whilst delivering a sub-therapeutic or unpredictable dose
[4] Jastreboff, A
Established manufacturers understand that new customers need to validate quality before committing to large orders, and they structure their offerings accordingly
